Dr. Vijaya Saratha Pulmonologist in Chennai

Dr. Vijaya Saratha

Pulmonologist, Chennai

MD, DNB, MRCP (UK), CCT (UK), PG.Med.Edu (UK)

  • 1 Hospital



Consultant Pulmonologist, Fortis Malar Hospital, Chennai


  • Pulmonology

  • Interventional Pulmonology

  • Respiratory Medicine


  • Asthma

  • Coronary Artery Disease (CAD)

    • Chronic ischaemic heart disease

    • Atherosclerotic cardiovascular disease

    • Atherosclerotic heart disease

  • Lung Cancer

  • Lung Diseases

  • Sleep Disorders


  • COPD oxygen therapy assessment and treatment, pulmonary rehabilitation
  • Lung Cancer diagnosis and planning of treatment
  • Sleep apnoea diagnosis and CPAP  treatment
  • Pleural diseases – Seldinger type chest drain insertion and Thoracoscopy
  • Interstitial lung disease


MBBS, 1993, Madras Medical College

MD, 1996, Madras Medical College

DNB, 1996, Madras Medical College

MRCP, 2000, Royal College of Physician

CCT (Respiratory and Internal Medicine, 2008, Royal College of Physician, UK

PG in Medical Education, 2011, University of Dundee, UK

Fellow in Interventional Pulmonary Fellow, 2011, Beth Israel Deaconess Medical Centre, Harvard university, Boston, USA

Practice Information

Fortis Malar Hospital, Chennai

Fortis Malar Hospital, Chennai

Gandhi Nagar, 52 First Main Road, Adyar, Chennai, Tamil Nadu - 600020


09:00 AM - 11:00 AM

Achievements & Contributions

  • COPD exacerbations and symptom diary card scoring, in COPD and Alpha 1 antitrypsin deficiency. journal.
  • Research officer/clinical investigator in the REPAIR trial, which is a multinational randomised double blinded placebo controlled clinical trial evaluating the efficacy of a special derivative of retinoic acid in promoting alveolar growth in patients with alpha 1 antitrypsin deficient emphysema – University Hospital Birmingham NHS Trust, UK 2006-2008, status- completed
  • The effects of short – term fluctuations in ambient air pollution on the respiratory exacerbations of Cystic fibrosis: UK 2003- 2004; Supervised by Dr. D E Stableforth – status – completed.
  • Serum trace elements levels in pulmonary tuberculosis patients before and after treatment with short course chemotherapy.
  • Drug trial. Comparing the therapeutic efficacy and side effect profiles of Roxithromycin vs. Cefaclor in the outpatient management of lower respiratory tract infection. Open label study: 1995 – Chennai, India.
  • Best outgoing MD student (TB and Respiratory), 1996
  • Best outgoing Student and Johnstone Medalist,  MBBS, 1991
  • First rank in State of Tamilnadu in SSLC, 1985
  • Royal College of Physicians London UK
  • European respiratory society
  • Indian Chest society

Patient Experience

Your participation in the survey will help other patients make informed decisions. You will also be helping Dr. Vijaya Saratha and her staff know how they are doing and how they can improve their services.